Daiichi Sankyo To Buy Astellas Pharma Inc. OTC Drug Unit, Zepharma Inc. For $200 Million

Published: Mar 30, 2006

Takashi Shoda (R), president of Daiichi Sankyo Co., and Masaji Oe, president of Zepharma Inc., stellas Pharma Inc.'s nonprescription drug unit, shake hands at a news conference at Daiichi Sankyo's head office in Tokyo on March 31. They announced Daiichi Sankyo will buy Zepharma for 23.5 billion yen. (Kyodo)

Back to news